Maria K Hordinsky

Active

Cultivating Care: Mobile Skin Clinic for Migrant Seasonal and Agricultural Workers in the state of Minnesota, USA

Hordinsky, M. K. (PI) & Goldfarb, N. (Co-Principal Investigator)

INTL LEAGUE OF DERMATOLOGICAL SOCIETIES

5/18/25 → 9/17/25

Project: Research project

A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-dose Study to Evaluate the Efficacy and Safety of VDPHL01 in Female Subjects with Androgenetic Alopecia

Hordinsky, M. K. (PI)

VERADERMICS INC

5/12/25 → 5/11/36

Project: Research project

B7981028 A LONG-TERM, DOUBLE-BLIND EXTENSION STUDY TO INVESTIGATE THE SAFETY AND EFFICACY OF RITLECITINIB IN PARTICIPANTS WITH SEVERE ALOPECIA AREATA WHO PREVIOUSLY COMPLETED STUDIES B7981027 OR B7981031

Hordinsky, M. K. (PI)

PFIZER, INC.

5/9/25 → 5/8/26

Project: Research project

A PHASE 3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF RITLECITINIB IN PEDIATRIC PARTICIPANTS 6 TO LESS THAN 12 YEARS OF AGE WITH SEVERE ALOPECIA AREATA

Hordinsky, M. K. (PI)

PFIZER, INC.

4/30/25 → 4/29/35

Project: Research project

A PHASE 3, EXTERNAL AND SYNTHETIC PLACEBO-CONTROLLED RANDOMIZED STUDY WITH DOSE-UP FOR NON-RESPONDERS TO INVESTIGATE SAFETY AND EFFICACY OF RITLECITINIB 50 MG...

Hordinsky, M. K. (PI)

PFIZER, INC.

3/17/25 → 3/16/35

Project: Research project

A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PARALLEL GROUP, MULTI-DOSE STUDY TO EVALUATE THE EFFICACY AND SAFETY OF VDPHL01 IN MALE SUBJECTS WITH ANDROGENETIC ALOPECIA

Hordinsky, M. K. (PI)

VERADERMICS INC

12/11/24 → 12/10/25

Project: Research project

PRESTO; Characterization and clinical outcomes of Alopecia Areata (AA) patients treated with ritlecitinib in a real-world (RW) cohort: A multinational, prospective observational study

Hordinsky, M. K. (PI)

PFIZER, INC.

6/10/24 → 6/9/35

Project: Research project

Protocol M23-716: A Phase 3 randomized, placebo-controlled, double-blind program to evaluate efficacyand safety of upadacitinib in adult and adolescent subjects with severe alopecia areata Protocol Date:01June 2023

Hordinsky, M. K. (PI)

ABBVIE INC

9/29/23 → 9/30/33

Project: Research project

A Phase 3, Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, and Pharmacokinetics of Baricitinib in Children from 6 Years to Less than 18 Years of Age with Alopecia Areata

Hordinsky, M. K. (PI)

ELI LILLY AND COMPANY

5/22/23 → 5/31/33

Project: Research project

A 6-month phase 3, multicenter, prospective, randomized, double-blind, vehicle-controlled study, to evaluate the efficacy and safety of topically applied clascoterone (cortexolone 17a-propionate) solution for the treatment of androgenetic alopecia in mal

Hordinsky, M. K. (PI)

CASSIOPEA, S.P.A.

4/10/23 → 4/30/28

Project: Research project

A Parallel Group Treatment, Phase 2a, Double-blind, Two-arm Study to Investigate the Efficacy and Safety of Farudodstat Tablets Compared with its Placebo in Male or Female Alopecia Areata Participants Aged 18 Years and Older with 50% or Greater Scalp Hai

Hordinsky, M. K. (PI)

ASLAN PHARMACEUTICALS (USA) INC

3/10/23 → 3/31/28

Project: Research project

A RANDOMIZED, DOUBLE-BLIND, VEHICLE-CONTROLLED, PARALLEL GROUP, MULTI-DOSE STUDY TOEVALUATE THE EFFICACY AND SAFETY OF TDM-105795 IN MALE SUBJECTS WITH ANDROGENETICALOPECIA

Hordinsky, M. K. (PI)

TECHNODERMA MEDICINES INC.

12/29/22 → 12/31/27

Project: Research project

A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety ofRosnilimab (ANB030) in the Treatment of Subjects with Alopecia Areata

Hordinsky, M. K. (PI)

ANAPTYSBIO, INC

12/9/21 → 12/31/26

Project: Research project

A MULTICENTER, OPEN-LABEL, EXTENSION STUDY TO ASSESS THE LONGTERM SAFETY ANDEFFICACY OF CTP-543 IN ADULT PATIENTS WITHMODERATE TO SEVERE ALOPECIA AREATA

Hordinsky, M. K. (PI)

CONCERT PHARMACEUTICALS, INC.

5/20/21 → 5/31/26

Project: Research project

A STUDY TO EVALUATE MAINTENANCE OF HAIR REGROWTH FOLLOWINGDOSE REDUCTION OF CTP-543 IN ADULT PATIENTS WITH MODERATE TOSEVERE ALOPECIA AREATA

Hordinsky, M. K. (PI)

CONCERT PHARMACEUTICALS, INC.

3/1/21 → 3/30/26

Project: Research project

A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CTP-543 IN ADULT PATIENTS WITH MODERATE TO SEVERE ALOPECIA AREATA

Hordinsky, M. K. (PI)

CONCERT PHARMACEUTICALS, INC.

5/1/20 → 7/30/25

Project: Research project

A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-MediatedInflammatory Skin Conditions

Hordinsky, M. K. (PI)

TARGET PHARMASOLUTIONS, INC

4/6/20 → 9/21/35

Project: Research project

A Multicenter, Randomized, Double-Blind, PlaceboControlled, Operationally Seamless, Adaptive Phase 2/3Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Severe or Very SevereAlopecia Areata

Hordinsky, M. K. (PI)

ELI LILLY AND COMPANY

8/6/18 → 2/28/26

Project: Research project

Maria K Hordinsky

Projects

Search results